Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A 67-year-old retiree turns savings into a steady monthly income using a three-ETF mix. The strategy aims to recreate...
Zcash’s price action is pinned to a single support zone around $360. Bulls are defending the line, but a break could ...
Vitalik Buterin unveiled a three-part framework for Ethereum, aiming to reshape the network’s use case and potentiall...
Stocks opened sharply lower on May 15, 2026, pushing the S&P 500 onto a heavier red backdrop as tech weakness and inf...
Oil prices jump as a threat from a former president signals potential U.S. control over Iran's oil exports, including...
A mixed-bag forecast brings heat, rain, snow, and Arctic chills across the United States, with notable implications f...
Occidental Petroleum is leading oil peers in early 2026, with a solid YTD run that outpaces ConocoPhillips and Diamon...
At Fortune Brainstorm Tech in Aspen, top executives say AI will augment human work—taking on repetitive tasks while p...
Traders are turning toward three mid-cap miners as the tape says these growth stocks could ride higher metal prices a...
Republic Services is tightening up near key moving averages, raising odds for a golden cross. This report surveys the...
A wave of AI adoption is shifting from hype to daily practice, with firms treating AI as a strategic partner and buil...